Genetic Analysis of the Chiari I Malformation
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
A observational or N/A phase clinical study on Syringomyelia and Type I Arnold Chiari Malformation, this trial is completed. The trial is conducted by National Institute of Neurological Disorders and Stroke (NINDS) and has accumulated 74 data snapshots since 2001. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Study Description(click to expand)Objectives: The goal of this study is to establish family pedigrees and undertake genetic linkage analysis that will identify gene loci associated with the Chiari I malformation and underdevelopment of the bone forming the posterior cranial fossa. Study Population: Patients and family members of patients with the Chiari I malformation. Because the research institutions are located in the United States and Russia, subjects will be recruited predominantly from these countries. Design: Human subjects will undergo 1) neurologic examinations, 2) head and cervical MRI scans to evaluate for the Chiari I malformation, syringomyelia, and maldevelopment of the posterior fossa, and 3) isolation and analysis of genomic DNA from whole blood for linkage analysis. Outcome Measures: Pedigrees will be established based on the MRI findings. The Chiari I phenotype will be defined as the caudal portion of the cerebellar tonsils lying greater than or equal to 2 mm below the foramen magnum and underdevelopment of the bone of the posterior fossa will be defined as 1) obliteration of the CSF pathways in the inferior portion of the posterior fossa, 2) posterior fossa volume to supratentorial volume ratio of less than or equal to 15%, or 3) abnormal shortening of the bones of...
Objectives: The goal of this study is to establish family pedigrees and undertake genetic linkage analysis that will identify gene loci associated with the Chiari I malformation and underdevelopment of the bone forming the posterior cranial fossa.
Study Population: Patients and family members of patients with the Chiari I malformation. Because the research institutions are located in the United States and Russia, subjects will be recruited predominantly from these countries.
Design: Human subjects will undergo 1) neurologic examinations, 2) head and cervical MRI scans to evaluate for the Chiari I malformation, syringomyelia, and maldevelopment of the posterior fossa, and 3) isolation and analysis of genomic DNA from whole blood for linkage analysis.
Outcome Measures: Pedigrees will be established based on the MRI findings. The Chiari I phenotype will be defined as the caudal portion of the cerebellar tonsils lying greater than or equal to 2 mm below the foramen magnum and underdevelopment of the bone of the posterior fossa will be defined as 1) obliteration of the CSF pathways in the inferior portion of the posterior fossa, 2) posterior fossa volume to supratentorial volume ratio of less than or equal to 15%, or 3) abnormal shortening of the bones of the skull base. Genetic analysis of the genomic DNA will be performed with DNA polymorphic markers to identify chromosomal loci linked to the small posterior fossa phenotype. A lod score of 3.0 (equivalent to 1000:1 odds in favor of linkage) will be taken as proof that the Chiari I gene maps to the same genetic region of the human genome as a given DNA marker.
Status Flow
Change History
74 versions recorded-
May 4, 2026 — Present [daily]
Completed
-
Apr 16, 2026 — May 4, 2026 [daily]
Completed
-
Feb 2026 — Apr 2026 [monthly]
Completed
-
Jan 2026 — Feb 2026 [monthly]
Completed
-
Dec 2025 — Jan 2026 [monthly]
Completed
▶ Show 69 earlier versions
-
Oct 2025 — Dec 2025 [monthly]
Completed
-
Sep 2025 — Oct 2025 [monthly]
Completed
-
Aug 2025 — Sep 2025 [monthly]
Completed
-
Jul 2025 — Aug 2025 [monthly]
Completed
-
Jun 2025 — Jul 2025 [monthly]
Completed
-
May 2025 — Jun 2025 [monthly]
Completed
-
Apr 2025 — May 2025 [monthly]
Completed
-
Mar 2025 — Apr 2025 [monthly]
Completed
-
Feb 2025 — Mar 2025 [monthly]
Completed
-
Jan 2025 — Feb 2025 [monthly]
Completed
-
Dec 2024 — Jan 2025 [monthly]
Completed
-
Nov 2024 — Dec 2024 [monthly]
Completed
-
Oct 2024 — Nov 2024 [monthly]
Completed
-
Sep 2024 — Oct 2024 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jun 2024 — Jul 2024 [monthly]
Completed
-
May 2024 — Jun 2024 [monthly]
Completed
-
Apr 2024 — May 2024 [monthly]
Completed
-
Mar 2024 — Apr 2024 [monthly]
Completed
-
Feb 2024 — Mar 2024 [monthly]
Completed
-
Jan 2024 — Feb 2024 [monthly]
Completed
-
Dec 2023 — Jan 2024 [monthly]
Completed
-
Oct 2023 — Dec 2023 [monthly]
Completed
-
Sep 2023 — Oct 2023 [monthly]
Completed
-
Aug 2023 — Sep 2023 [monthly]
Completed
-
Jul 2023 — Aug 2023 [monthly]
Completed
-
Jun 2023 — Jul 2023 [monthly]
Completed
-
May 2023 — Jun 2023 [monthly]
Completed
-
Apr 2023 — May 2023 [monthly]
Completed
-
Feb 2023 — Apr 2023 [monthly]
Completed
-
Jan 2023 — Feb 2023 [monthly]
Completed
-
Dec 2022 — Jan 2023 [monthly]
Completed
-
Nov 2022 — Dec 2022 [monthly]
Completed
-
Sep 2022 — Nov 2022 [monthly]
Completed
-
Jul 2022 — Sep 2022 [monthly]
Completed
-
Jun 2022 — Jul 2022 [monthly]
Completed
-
May 2022 — Jun 2022 [monthly]
Completed
-
Apr 2022 — May 2022 [monthly]
Completed
-
Jan 2022 — Apr 2022 [monthly]
Completed
-
Nov 2021 — Jan 2022 [monthly]
Completed
-
Sep 2021 — Nov 2021 [monthly]
Completed
-
Jun 2021 — Sep 2021 [monthly]
Completed
-
Mar 2021 — Jun 2021 [monthly]
Completed
-
Jan 2021 — Mar 2021 [monthly]
Completed
-
Dec 2020 — Jan 2021 [monthly]
Completed
-
Nov 2020 — Dec 2020 [monthly]
Completed
-
Sep 2020 — Nov 2020 [monthly]
Completed
-
Aug 2020 — Sep 2020 [monthly]
Completed
Status: Recruiting → Completed
-
Jul 2020 — Aug 2020 [monthly]
Recruiting
-
Jun 2020 — Jul 2020 [monthly]
Recruiting
-
May 2020 — Jun 2020 [monthly]
Recruiting
-
Apr 2020 — May 2020 [monthly]
Recruiting
-
Mar 2020 — Apr 2020 [monthly]
Recruiting
-
Feb 2020 — Mar 2020 [monthly]
Recruiting
-
Dec 2019 — Feb 2020 [monthly]
Recruiting
-
Nov 2019 — Dec 2019 [monthly]
Recruiting
-
Oct 2019 — Nov 2019 [monthly]
Recruiting
-
Jun 2019 — Oct 2019 [monthly]
Recruiting
-
May 2019 — Jun 2019 [monthly]
Recruiting
-
Apr 2019 — May 2019 [monthly]
Recruiting
-
Mar 2019 — Apr 2019 [monthly]
Recruiting
-
Feb 2019 — Mar 2019 [monthly]
Recruiting
-
Nov 2018 — Feb 2019 [monthly]
Recruiting
-
Oct 2018 — Nov 2018 [monthly]
Recruiting
-
Sep 2018 — Oct 2018 [monthly]
Recruiting
-
Jul 2018 — Sep 2018 [monthly]
Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Jun 2001
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
The purpose of this study is to better understand the genetic factors related to the Chiari I malformation. In people with this abnormality, the lower part of the skull is smaller than normal. As a result, the lowest part of the brain, called the cerebellar tonsils, protrudes out of the hole at the bottom of the skull into the spinal canal. This study will try to discover the location of the genes responsible for the malformation. Candidates for this study are: 1) Patients with Chiari I malformation who also have a family member with the abnormality or a family member with syringomyelia (a cyst in the spinal cord that is often associated with the Chiari I malformation). 2) Family members of patients with the Chiari I malformation. Participants will have a medical history and physical and neurologic examinations. They will undergo magnetic resonance imaging (MRI) of the brain and cervical (neck) spinal cord to measure the size of the head and determine the presence of the Chiari I malformation and syringomyelia. A small blood sample (about 2 tablespoons) will be drawn for DNA studies relating to the Chiari I malformation. ...
Contact Information
- National Institute of Neurological Disorders and Stroke (NINDS)
For direct contact, visit the study record on ClinicalTrials.gov .